A detailed history of Advisor Net Financial, Inc transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Advisor Net Financial, Inc holds 5,135 shares of NTLA stock, worth $78,103. This represents 0.01% of its overall portfolio holdings.

Number of Shares
5,135
Previous 5,100 0.69%
Holding current value
$78,103
Previous $114,000 7.89%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$19.72 - $27.36 $690 - $957
35 Added 0.69%
5,135 $105,000
Q2 2024

Jul 16, 2024

BUY
$20.02 - $27.22 $39,639 - $53,895
1,980 Added 63.46%
5,100 $114,000
Q1 2024

Apr 12, 2024

BUY
$23.82 - $32.8 $26,583 - $36,604
1,116 Added 55.69%
3,120 $85,000
Q4 2023

Jan 19, 2024

BUY
$23.16 - $32.34 $92 - $129
4 Added 0.2%
2,004 $61,000
Q1 2021

Apr 14, 2021

BUY
$46.59 - $83.68 $93,180 - $167,360
2,000 New
2,000 $161,000

Others Institutions Holding NTLA

About Intellia Therapeutics, Inc.


  • Ticker NTLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,011,800
  • Market Cap $1.16B
  • Description
  • Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...
More about NTLA
Track This Portfolio

Track Advisor Net Financial, Inc Portfolio

Follow Advisor Net Financial, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Net Financial, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Advisor Net Financial, Inc with notifications on news.